Rare lobster moves to CT to be displayed. NY store said he was ‘way too good to eat'
Jerry the Golden Lobster arrived in ShopRite of Carmel, according to a Facebook post by the grocery store on June 30.
'A golden lobster, a 1 in 30 million chance, has made its way to the ShopRite of Carmel. We've named him Jerry, and tomorrow, this rare lobster that's way too good to eat will be heading to the Mystic Aquarium in Connecticut. It is here he'll live out his days bringing joy to visitors from near and far. Swim free, Jerry. We'll miss you,' the Facebook post said.
A manager at the store said media requests had to be done through a corporate office, which was closed due the holiday. See a photo of the lobster here.
A second post by the store said the lobster had arrived in Connecticut. A message seeking comment was left with the aquarium.
According to a story on the U.S. National Science Foundation website, the golden color may be an effect of climate change.
'Roughly 1 in 30 million lobsters has the genetic mutation that causes the yellow shell color, and there are many different color varieties, including bright blue, calico (black and orange) and the rarest of all — white lobsters,' according to the U.S. National Science Foundation story.
Further, according to the Seacoast Science Center, lobster shell color 'is determined by a complex interplay of three layers of carotenoid pigments that bind with proteins: astaxanthin (reds and yellows), and crustacyanin (blues). In a typical lobster, these stacked pigments combine in the shell to produce the familiar dark camouflage coloration. When genetic mutations alter the expression, or structure, of these pigments, uncommon colors can emerge.'
The center also noted, 'Whilst stumbling across a colored lobster is a rare event, it is a potent reminder of the complexity and variability of life. Each colored lobster is not only a biological curiosity but also a window into the intricate genetic mechanisms that drive diversity in the natural world.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
‘Jurassic World Rebirth' roars to top of the box office
Dinosaurs are alive and well at the box office as Universal's 'Jurassic World Rebirth' trampled competitors, grossing $147 million domestically over five days of the Fourth of July weekend. The fourth installment of the 'Jurassic World' series outperformed early estimates of nearly $80 million for the three days and $135 million for the five days. It nearly matched its predecessor from 2022, 'Jurassic World Dominion,' which grossed $145 million in its first three days before raking in over $1 billion worldwide. 'Jurassic World Rebirth' is another win for Hollywood, which has effectively rebounded from a sluggish start to 2025. The box office is up more than 14% year-to-date compared with last year, according to Comscore, which collects box office data. The summer season, which Comscore begins tracking on the first Friday in May, is faring even better — up 15% compared to 2024. 'Jurassic Park Rebirth' is the seventh film in the franchise, which began with Steven Spielberg's 'Jurassic Park' in 1993. The original movie would go on to gross $924 million worldwide, or $2 billion when adjusted for inflation. While 'Jurassic World' was a new era for the franchise, calling the fourth film 'Rebirth,' and casting Scarlett Johansson, likely reinvigorated the brand, according to Paul Dergarabedian, a senior media analyst at Comscore. 'This brand will never go extinct because it continues to thrill audiences,' he said. 'It's most impressive to have a franchise three decades old, topping the chart once again.' 'Jurassic World Rebirth' knocked Apple and Warner Bros. Pictures' 'F1' down a peg to No. 2. 'F1' grossed $26 million domestically this weekend, a 54% drop from the week prior. The racing movie starring Brad Pitt opened last weekend to roughly $55.6 million domestically and $144 million worldwide. Warner Bros. Discovery is the parent company of CNN. ''F1' is interesting because it's absolutely killing it at the international box office,' said Dergarabedian. '(It's) a sport that is more internationally centric than in the United States.' 'Jurassic World Rebirth' and 'F1' will face fierce competition next week when Warner Bros.' 'Superman' opens in theaters. Analysts expect 'Superman' to gross over $100 million in its opening weekend. 'The best thing for 'Superman' is the success of 'Jurassic' and 'F1.' The rising tide raises all ships,' said Dergarabedian. Shawn Robbins, director of analytics at Fandango and founder and owner of Box Office Theory, said the releases of 'Jurassic World Rebirth,' 'Superman,' and Disney's 'The Fantastic Four: First Steps' (July 25) could account for about a quarter of the domestic box office this summer. Robbins added that 'F1,' 'Jurassic World Rebirth' and 'Superman' will likely attract similar audiences of young men. 'Superman' could also appeal to families and younger audiences. 'It's summer. It's the time when multiple films can coexist, so if any of them are going to do it, this is a good set of movies to pull it off,' he said.
Yahoo
2 hours ago
- Yahoo
FDA Approved Thermo Fisher Scientific's (TMO) Oncomine Dx Express Test
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the . On July 3, Thermo Fisher Scientific Inc. (NYSE:TMO) announced receiving FDA approval for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. After the approval, this test is now authorized as an in vitro diagnostic and as a companion diagnostic for Dizal's ZEGFROVY. ZEGFROVY is a targeted therapy for non-small cell lung cancer patients with EGFR exon 20 insertion mutations. The test is also approved for broader tumor profiling in solid tumors, detecting mutations across 46 genes with clinical or potential clinical significance. A workstation in a research lab stocked with laboratory products and services. This is a significant achievement as it brings rapid next-generation sequencing closer to patients. The technology can deliver crucial genomic results in as little as 24 hours. This speed is important for cancer care, as delays in obtaining tumor profiles can prevent patients from receiving timely treatments. Thermo Fisher Scientific Inc. (NYSE:TMO) is a healthcare company that is focused on accelerating research, solving complex analytical problems, boosting laboratory efficiency, and improving patient health. While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
4 hours ago
- Yahoo
Bending Bones, Stretchy Ligaments: UT's 3D Printer Redefines Medical Implants
In a groundbreaking achievement that almost blurs the lines between science fiction and reality, researchers at The University of Texas at Austin have unveiled a new 3D printing technique that can combine soft and stretchable materials with other tough or rigid resins in a single, precise print. Inspired by the 'natural world,' think of the way bone transitions smoothly into cartilage: the new printing process allows engineers to create objects that can bend and flex when needed while also staying firm and supportive. Scientists at the University of Texas outlined to The Dallas Express that this breakthrough results in next-level prosthetics, modern flexible medical implants, and even wearable electronics that move and feel more like human tissue than ever before. 'By enabling precise control over both shape and material properties, our multimaterial 3D printing technology allows for the creation of devices that more closely mimic the complex mechanics of the human body,' Dr. Zak Page, Assistant Chemistry Professor at The University of Texas at Austin, told DX. 'Whether it's a prosthetic interface, a patient-specific surgical model, or a wearable health sensor, the ability to print gradual transitions between soft and rigid materials opens new possibilities for comfort, performance, and personalization across a wide range of medical applications,' Page added. The research results published earlier this week describe how the team achieved the 3D advancement using a custom-designed resin and a dual-light printing system. By simply changing the color of light during printing —violet for soft or rubbery parts and ultraviolet for more rigid sections —they were able to build objects with new gradients of flexibility and strength. A standout demo resulted in a tiny, functional 3D-printed 'knee joint,' complete with bending ligaments and sturdy bones that move together smoothly. Page said in the report that the first print was a surprise success. 'Honestly, what surprised me most was how well it worked on the first try. That almost never happens with 3D printing resins,' he said. 'We were also shocked by how different the properties were. The soft parts stretched like a rubber band and bounced back. The hard parts were as strong as plastics used in consumer products.' The new 3D printing technique also boasts faster speeds, and the necessary equipment isn't out of reach for smaller labs or hospitals worldwide. This could potentially result in easier access to medical equipment for isolated communities worldwide. 'This approach could make additive manufacturing more competitive for higher-volume production compared with traditional processes like injection molding. Just as important, it opens up new design possibilities,' added Keldy Mason, lead author of the university study and a graduate student in Page's lab.
